Ascento Medical

AI-based Solution for Dementia and Alzheimer's Disease

Health Tech & Life Sciences
Non Active, Nov 2023

Company Overview

Snapshot

Founded in February 2020 by Rami Cohen and Eli Wertman, Ascento Medical operates with 1–10 employees. The company has raised $1 million across three funding rounds and has attracted two investors. In January 2022, Ascento Medical partnered with Hadassah Medical to establish an innovative Dementia/Alzheimer's Clinic.

Business overview

Ascento Medical is a digital health company focused on developing AI and machine learning solutions for the treatment and prevention of dementia and Alzheimer's disease. The company optimizes a proven treatment method by leveraging key information extracted from hundreds of medical files to generate personalized treatment plans. Ascento Medical's solution aims to reduce healthcare costs for HMOs by decreasing hospitalization rates while providing clinicians with advanced tools for personalized patient care in the Health Tech & Life Sciences sector.

Strategic signal

In January 2022, Ascento Medical announced a strategic partnership with Hadassah Medical to establish a new Dementia/Alzheimer's Clinic. This collaboration signals strong institutional validation for Ascento Medical's AI-powered approach to dementia care, demonstrating a commitment to integrating advanced technology into clinical practice and expanding access to specialized treatment for patients.

Company Intelligence Q&A

What is Ascento Medical's primary focus?
Ascento Medical develops AI-based solutions for treating and preventing dementia and Alzheimer's disease, leveraging machine learning to optimize existing treatment methods.
When was Ascento Medical founded?
Ascento Medical was founded in February 2020.
What significant partnership did Ascento Medical form?
In January 2022, Ascento Medical joined forces with Hadassah Medical to establish an innovative Dementia/Alzheimer's Clinic.
How much capital has Ascento Medical raised?
Ascento Medical has raised a total of $1 million across three funding rounds.
What is the core technology behind Ascento Medical's solution?
Ascento Medical utilizes artificial intelligence and machine learning to analyze patient data and generate personalized treatment programs for dementia and Alzheimer's disease.